DOCSLIB.ORG

Incidence, Prevalence and Healthcare Outcomes in Idiopathic Intracranial

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Incidence, Prevalence and Healthcare Outcomes in Idiopathic Intracranial Published Ahead of Print on January 20, 2021 as 10.1212/WNL.0000000000011463 Neurology Publish Ahead of Print DOI: 10.1212/WNL.0000000000011463 Incidence, Prevalence and Healthcare Outcomes in Idiopathic Intracranial Hypertension: A Population Study Latif Miah MBBCh1*; Huw Strafford MSc1*; Beata Fonferko-Shadrach MPH1; Joe Hollinghurst PhD1; Inder MS Sawhney MD1,2; Savvas Hadjikoutis MD2, Mark I Rees DSc1,3; Rob Powell PhD1,2; Arron Lacey PhD1; W Owen Pickrell PhD1,2 The Article Processing Charge was funded by Health Data Research (HDR) UK. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Neurology® Published Ahead of Print articles have been peer reviewed and accepted for publication. This manuscript will be published in its final form after copyediting, page composition, and review of proofs. Errors that could affect the content may be corrected during these processes. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. Author affiliations: 1Swansea University Medical School, Swansea University, Swansea; 2Neurology Department, Morriston Hospital, Swansea Bay University Health Board; 3Faculty of Medicine and Health, University of Sydney. *These authors contributed equally to the manuscript Online supplementary data (uploaded as a separate file to Zenodo repository): Tables e-1 to e-8, Figures e-1 to e-5 Web Address: https://zenodo.org/record/4064064 File name: Supp_Data_IIH.docx Keywords: Idiopathic intracranial hypertension, Cohort studies, Prevalence studies, Incidence studies, Quality of life Publication History: This article has not been published previously Submission Type: Article Title character count: 104 Number of Tables: 2 Number of Figures: 5 Number of References: 23 Word count (abstract): 244 Word count (paper): 3567 Corresponding author: Dr. William Owen Pickrell [email protected]. DISCLOSURES The authors report no relevant disclosures to this manuscript. STATISTICAL ANALYSIS was conducted by Mr, Huw Strafford MSc, Dr Joe Hollinghurst PhD and Dr W Owen Pickrell PhD. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. STUDY FUNDING The study was not directly funded but we acknowledge support from the Brain Repair and Intracranial Neurotherapeutics (BRAIN) Unit and the Wales Gene Park which are funded by Health and Care Research Wales. This work was supported by Health Data Research UK, which receives its funding from HDR UK Ltd (HDR-9006) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ABSTRACT Objective: To characterise trends in incidence, prevalence, and healthcare outcomes in the idiopathic intracranial hypertension (IIH) population in Wales using routinely collected healthcare data. Methods: We used and validated primary and secondary care IIH diagnosis codes within the Secure Anonymised Information Linkage databank, to ascertain IIH cases and controls, in a retrospective cohort study between 2003 and 2017. We recorded body mass index (BMI), deprivation quintile, CSF diversion surgery and unscheduled hospital admissions in case and control cohorts. Results: We analysed 35 million patient years of data. There were 1765 cases of IIH in 2017 (85% female). The prevalence and incidence of IIH in 2017 was 76/100,000 and 7.8/100,000/year, a significant increase from 2003 (corresponding figures=12/100,000 and 2.3/100,000/year) (p<0.001). IIH prevalence is associated with increasing BMI and increasing deprivation. The odds ratio for developing IIH in the least deprived quintile compared to the most deprived quintile, adjusted for gender and BMI, was 0.65 (95% CI 0.55 to 0.76). 9% of IIH cases had CSF shunts with less than 0.2% having bariatric surgery. Unscheduled hospital admissions were higher in the IIH cohort compared to controls (rate ratio=5.28, p<0.001) and in individuals with IIH and CSF shunts compared to those without shunts (rate ratio=2.02, p<0.01). Conclusions: IIH incidence and prevalence is increasing considerably, corresponding to population increases in BMI, and is associated with increased deprivation. This has important implications for healthcare professionals and policy makers given the comorbidities, complications and increased healthcare utilization associated with IIH. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. INTRODUCTION Idiopathic Intracranial Hypertension (IIH) is a condition of unknown etiology that is strongly associated with obesity. IIH predominantly affects women of childbearing age and causes chronic disabling headaches, visual disturbance and, in a minority of patients, permanent visual loss. The definitive management is weight loss but a minority of patients require surgery in order to preserve vision.1,2 People with IIH potentially have high rates of healthcare utilization due to their comorbidities, multiple specialist consultations, diagnostic tests, CSF diversion procedures and complications related to CSF diversion surgery. Given the increasing global burden of obesity and the strong association of IIH with obesity, it would seem plausible to assume that the incidence of IIH, as well as associated healthcare utilization, is increasing.3,4 Although there is some evidence to support this,1,4 overall there is a paucity of data regarding the epidemiology, healthcare utilization and outcomes of people with IIH. Large population level studies of IIH in Wales are rare, if available. In this retrospective cohort study, we aimed to determine the temporal trends of IIH incidence and prevalence in Wales, and healthcare utilization associated with IIH. We also investigated the effects of socioeconomic deprivation and obesity on IIH epidemiology. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. METHOD This was a retrospective cohort study using anonymized, routinely collected Welsh healthcare data within the Secure Anonymised Information Linkage databank (SAIL) at Swansea University, Wales, United Kingdom (UK).5,6,7 SAIL contains anonymized linked datasets from a range of Welsh health sources including hospital admission and demographic data for the complete Welsh population (3.1 million, 2017 population estimate) and primary care records for approximately 80% of the Welsh population. SAIL uses an established and validated split-file approach for anonymized data linkage.5,6 In the UK, primary care consists primarily of general practitioners (GP). Patients with IIH can first present to their GP, optometry, neurology or the emergency department before being given a diagnosis by ophthalmologists or neurologists in secondary care. To validate the accuracy of IIH diagnosis codes in routinely collected data, we anonymously linked a list of successive definite and probable IIH cases in 2016 and 2017 from Morriston Hospital Swansea (the regional neurosciences center) with SAIL data. The IIH cases were reviewed by clinicians and classed as definite if they met all IIH criteria or probable if they met the criteria but a record of fundoscopy at the time of diagnosis could not be found (table e-1).8 Additionally, we reviewed all patients that were admitted to Morriston hospital in 2017 with an IIH ICD10 diagnosis code in their hospital admission record and checked whether they had also been given a diagnosis of IIH by a consultant neurologist. Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. To identify patients with IIH throughout Wales, we selected patients who had been given primary care and/or secondary care IIH diagnosis codes (table e- 2) within the study window (1st January 2003 to 31st December 2017). We excluded likely cases of secondary intracranial hypertension (central nervous system malignancies, venous sinus thrombosis and malignant hypertension) (table e-3). We also excluded patients with less than one year of primary care data prior to diagnosis, insufficient demographic data and those who were diagnosed on their death date (figure e-1). We recorded bariatric surgery procedures and CSF diversion and revision procedures within the IIH cohort (tables e-4, e-5 and e-6 for codes). We calculated incidence and prevalence for every year within the study window and also calculated incidence and prevalence for each of the seven health boards within Wales. We recorded deprivation using the Welsh Index of Multiple Deprivation (WIMD), 2011 version, in which Wales is divided into 1897 Lower Super Output Areas (LSOAs) containing an average of 1600 people.9 Weighted scores from eight domains, representing different types of deprivation, are aggregated to form a WIMD score for each LSOA. The following are the eight domains which provide the
Load more

Recommended publications
  • Candidate Information Pack
    Candidate Information Contents Section 1 – Welcome and Foreword 3 Section 2 – The NHS in Wales 5 Section 3 – Purpose, vision, aims and values 7 Section 4 – How we are structured and overview of services 9 Section 5 – Strategic change, challenges and planning 14 Section 6 – Working in partnership with Universities 18 Section 7 – A very special and unique place to live and work 25 Chairman’s Foreword Dear Candidate ABMU Health Board is ambitious - we aim to create a new model of a 21st century health economy, based on our core values of Caring for Each Other, Working Together and Always Improving. We want an Executive Director who shares our values and has ambition, drive and determination to help us create that. In Wales, NHS policy is the responsibility of the Welsh Government and health policy has diverged significantly from that operating in England where a market-driven system, increasingly based on competition, has developed. In Wales the emphasis is on collaboration not competition. Unlike in England, the seven Health Boards in Wales Andrew Davies, Chairman deliver an integrated service and are responsible for both commissioning and planning all levels of citizen-centred healthcare services, as well as delivering them. In practice, this means that ABMU Health Board is delivering - and developing - services which range from primary and community health care, mental health, and responsibility for public health, through to highly specialised tertiary services. We are doing this in close partnership with our local authority, third sector
    [Show full text]
  • Patient Experience Report April - June 2019
    Appendix 1 Patient Experience Report April - June 2019 This report provides information on Patient Feedback and Experience, what it means and how we are using it to improve the service. Included within this report is the current performance of The Health Board’s Service Delivery Units and learning. Index 1. Patient Experience Update ........................................ Page 2 2. Learning from Events............................................... Page 9 3. Compliments ................................................................ Page 12 4. Concerns Management................................................. Page 13 5. Patient Safety Solutions ………………………………… Page 15 6. Arts in Health................................................................. Page 16 7. Delivery Unit Reports .................................................... Page 19 __________________________________________________________________________________________ 1 1. PATIENT EXPERIENCE 1.1 Inpatient Discharge Feedback Rates The Patient Experience Team continues to provide support and guidance to the Service Delivery Units (“SDU”) on increasing the number of surveys completed. The graph below indicates the discharge feedback rate benchmarked against the best performing Trusts for patient feedback returns in NHS England (35%). The Health Board’s aim is to increase the rate to 35%. April 2019 was 24.16%, May 2019 was 23.32% and June 2019 was 26.56%. Apr-19 May-19 Jun-19 NHS England Discharge 35.0% 35.0% 35.0% Swansea Bay UHB Inpatient Discharge 24.2% 23.3% 26.6% __________________________________________________________________________________________
    [Show full text]
  • Abertawe Bro Morgannwg Nhs Trust
    EXTREME WEATHER CONDITIONS POLICY AND PROCEDURE. This document may be made available in alternative formats and other languages, on request, as is reasonably practicable to do so. The policy has been screened for relevance to equality. No potential negative impact has been identified so a full equality impact assessment is not required. Policy Owner: Director of Workforce and OD Approved by: Health Board Partnership Forum Issue Date: December 2009 Revised: January 2020 Review Date: February 2021 Policy ID: HB69 Revised January 2020 Revised February 2015: Amendments: Section 3.1b- Staff are required to attend a Swansea Bay University Health Board site if they are able to do so. They should not report to health care sites outside of Swansea Bay University Health Board. Section 5.1- Staff employed by another NHS Health Board who attend premises within Swansea Bay University Health Board, must not be a permitted to work. (Agreed by HBPF 10th February 2015) Revised March 2018 Amendments: Section 4.3. The decision to pay staff for additional hours worked will be made by the Service Director or their designated representative. Section 4.8. Clarifies the position in the policy that where employees are not entitled to paid leave for their absence in accordance with section 3, and annual leave, time in lieu or working back the hours at another time are not available, the time off will be unpaid. (Agreed – HBPF- 1st March 2018) Revised January 2020: Amendments: Section 3.1 and section 5.1 amended to make reference to the Interim Procedure for Volunteer Staff Deployment during Adverse Weather.
    [Show full text]
  • Development of a Mid and South West Wales Regional Centre Of
    Name of Meeting Board Date of Meeting 28 March 2019 Agenda item: 9.2.280319 Development of a Mid and South West Wales Regional Centre of Excellence Cellular Pathology Laboratory, Regional Diagnostic Immunology Laboratory & Regional Medical Microbiology Facility at Morriston Hospital, Swansea Executive lead: Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director Author: Ms Heather Edwards, Business Planning Manager, Abertawe Bro Morgannwg University Health Board, with amendment where necessary by Dr Quentin Sandifer, Executive Director of Public Health Services and Medical Director Approval/Scrutiny Business Executive Team, 18 March 2019 route: Purpose To seek Board approval on the Strategic Outline Case (SOC) prior to submission to Welsh Government. Nationally NHS Pathology services face a number of challenges. Within the Mid and South West Wales’ region, Hywel Dda University Health Board (HDUHB), Abertawe Bro Morgannwg University Health Board (ABMUHB) and Public Health Wales NHS Trust (PHW) are struggling to manage workforce and sustainability pressures, to maintain quality and safety issues and to meet clinically driven targets. Without investment in sustainable services we cannot deliver essential improvements and fit for purpose laboratories. Investment would allow us to co-locate and develop regionalised services and to support more innovative and sustainable service models which could be future-proofed, and be flexible enough, to respond to changing demand, new technologies and innovations. In 2017 a South West Wales Regional Pathology Reconfiguration Project Board was established to draft a Strategic Outline Business Case (SOC) to address these regional challenges in line with the national direction of travel for regional pathology services.
    [Show full text]
  • Morriston ED
    Hospital Inspection (Unannounced) Morriston Hospital, Swansea Bay University Health Board. Emergency Department and Acute Medical Admission Unit. Inspection date: 27 to 29 January 2020. Publication date: 06 August 2020 This publication and other HIW information can be provided in alternative formats or languages on request. There will be a short delay as alternative languages and formats are produced when requested to meet individual needs. Please contact us for assistance. Copies of all reports, when published, will be available on our website or by contacting us: In writing: Communications Manager Healthcare Inspectorate Wales Welsh Government Rhydycar Business Park Merthyr Tydfil CF48 1UZ Or via Phone: 0300 062 8163 Email: [email protected] Fax: 0300 062 8387 Website: www.hiw.org.uk Digital ISBN978-1-80038-996-0 © Crown copyright 2020 Contents 1. What we did ....................................................................................................... 6 2. Summary of our inspection ................................................................................ 7 3. What we did ..................................................................................................... 10 Quality of patient experience .......................................................................... 13 Delivery of safe and effective care ................................................................. 28 Quality of management and leadership .......................................................... 46 4. What next? ......................................................................................................
    [Show full text]
  • Swansea Bay University Health Board
    Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Swansea Bay University Health Board Issue No: 007 Issue date: 09 June 2021 ABM University Health Board Contact: Dr Andar Gunneberg Headquarters Tel: +44 (0) 1792 703988 1 Talbot Gateway 8918 E-Mail: [email protected] Port Talbot Website: www.abm.wales.nhs.uk SA12 7BR Accredited to ISO 15189:2012 Testing performed by the Organisation at the locations specified below Locations covered by the organisation and their relevant activities Laboratory locations: Location details Activity Location code Pathology Department Local contact Clinical Biochemistry M Morriston Hospital Dr Andar Gunneberg Haematology Heol Maes Eglwys Immunology Morriston Blood Transfusion Swansea Phlebotomy SA6 6NL Management of two lab-based blood fridges B Pathology Department Local contact Clinical Biochemistry Princess of Wales Hospital Dr Andar Gunneberg Haematology Coity Road Toxicology Bridgend Blood Transfusion CF31 1RQ Phlebotomy Management of two lab-based blood fridges Pathology department Local contact Clinical Biochemistry S Singleton Hospital Dr Andar Gunneberg Haematology Sketty Lane Blood Transfusion Swansea Phlebotomy SA2 8QA Management of two lab-based blood fridges Hot lab Local contact Full blood count MHL Pathology Department Dr Andar Gunneberg Routine coagulation tests Morriston Hospital Heol Maes Eglwys Morriston Swansea SA6 6NL Assessment Manager: AB2 Page 1 of 24 Schedule of Accreditation issued by United
    [Show full text]
  • Pre-Appointment Hearing - Chair of Swansea Bay University Health Board
    National Assembly for Wales Health, Social Care and Sport Committee Pre-appointment Hearing - Chair of Swansea Bay University Health Board March 2020 1. Introduction 1. On 12 March 2020, the Committee held a pre-appointment hearing with Emma Woollett, the Welsh Government’s preferred candidate for the position of Chair of Swansea Bay University Health Board (UHB). The meeting transcript is available on the Committee’s website. 2. To inform the hearing, the Committee asked the preferred candidate to respond to a questionnaire, which is included at Annexe A. 1.1 Background 3. Swansea Bay University Health Board (formerly Abertawe Bro Morgannwg University Health Board (ABMU)) was created on 1 April 2019, after responsibility for providing healthcare services in the Bridgend County Borough Council area passed from ABMU to the new Cwm Taf Morgannwg University Health Board. 4. Swansea Bay UHB covers a population of around 390,000 in the Neath Port Talbot and Swansea areas and has a budget of around £1bn. The health board employs approximately 12,500 staff. 1 5. It has three major hospitals providing a range of services: Morriston and Singleton in Swansea, and Neath Port Talbot Hospital in Baglan, Port Talbot. It also has a community hospital and primary care resource centres providing clinical 1 Details taken from the ‘Information for Candidates’ document, which accompanied the advertisement for the role www.assembly.wales Pre-appointment Hearing – Chair of Swansea Bay University Health Board services outside the main hospitals. There are 49 GP practices in the health board area, 72 dental practices including orthodontists, 31 optometry practices and 92 community pharmacies.
    [Show full text]
  • Care of the Elderly Consultant
    Care of the Elderly Consultant Job Pack INTEGRATED DEPARTMENT OF MEDICINE FOR OLDER PEOPLE FOUR CONSULTANT PHYSICIANS in GERIATRIC MEDICINE We have exciting and ambitious plans for our Care of the Elderly services, spanning a wide range of hospital and community services, and all aimed at providing high quality, compassionate care. Background The population served by Swansea Bay is ageing and the prevalence of frailty is increasing. This demand this places on the health and social care system is one of our biggest challenges, but one we are determined to meet. We need the right calibre of people to join our growing team and help us do this. As a health board in Wales, primary, community and hospital services are all within our one organisation and this makes developing and delivering services so much better. We are building an Integrated Department of Medicine for Older People which aims to: Support older people to live well in the community, including management of complex co-morbidities, dementia and frailty Provide rapid support close to home at times of crisis Deliver good acute hospital care when needed Offer high quality rehabilitation and re-ablement after acute illness or injury including good discharge planning and support Offer choice, control and support toward end of life How are we planning to do this? Comprehensive geriatric assessment is the gold standard for assessing older people living with frailty and leads to better outcomes for patients. Optimal outcomes are only achieved when community health and social care services and hospital systems are fully aligned, well-coordinated and integrated, and this is at the heart of our growing service.
    [Show full text]
  • Serving the Population of South Wales, West Wales and South Powys
    Serving the population of South Wales, West Wales and South Powys Programme Business Case 26 November 2019 For reporting to Health Boards 1 Acknowledgements The authors would like to thank all those who have contributed to the programme over the last five years and to the development of this Programme Business Case. Authors Rosemary Fletcher Director, NHS Wales Health Collaborative Dr Dinendra Gill Clinical Lead, South Wales Trauma Network Rhys Blake Head of Planning, NHS Wales Health Collaborative Jeremy Surcombe Programme Manager, NHS Wales Health Collaborative Vickie Harding Project Support Officer, NHS Wales Health Collaborative 2 Contents 1 Executive Summary .................................................................................................. 8 1.1 Introduction ............................................................................................................................. 8 1.2 Vision ....................................................................................................................................... 8 1.3 Background .............................................................................................................................. 8 1.4 Strategic Case .......................................................................................................................... 8 1.5 Case for Change ....................................................................................................................... 9 1.6 Clinical and Operational Model ............................................................................................
    [Show full text]
  • Summary Report for the Team
    Appendix 1 Patient Experience Report October 2018 – February 2019 This report provides information on Patient Feedback and Experience, what it means and how we are using it to improve the service. Included within this report is the current performance of The Health Board’s Service Delivery Units and learning. Index 1. Patient Experience Update ........................................ Page 2 2. Learning from Events............................................... Page 7 3. Compliments ................................................................ Page 10 4. Concerns Management................................................. Page 11 5. Patient Safety Solutions ………………………………… Page 15 6. Arts in Health................................................................. Page 16 7. Delivery Unit Reports .................................................... Page 17 __________________________________________________________________________________________ 1 1. PATIENT EXPERIENCE 1.1 Inpatient Discharge Feedback Rates The Patient Experience Team continues to provide support and guidance to the Service Delivery Units (“SDU”) on increasing the number of surveys completed. The graph below indicates the discharge feedback rate benchmarked against the best performing Trusts for patient feedback returns in NHS England (35%). The Health Board’s aim is to increase the rate to 35%. October 2018 was 22.85%, November 2018 was 24.09%, December 2018 was 17.99%, January 2019 was 17.16% and February 2019 was 21.16%. __________________________________________________________________________________________
    [Show full text]
  • Singleton Hospital
    Singleton Hospital - City Centre - Morriston Hospital 4 via Civic Centre, Stadium (Park & Ride) & Morriston Cross Singleton Hospital - City Centre - Parc Gwernfadog - Morriston Hospital 4A via Civic Centre, Liberty Stadium, Morriston Cross & Llanllienwen Close Mondays to Fridays (University Term Time Only) Service Number 4A 4A 4 4 4 4 4 4 4 4 4 4 Singleton Hospital .... .... 0716 .... 0734 0744 0754 0804 0814 1814 1824 1836 Swansea University (Singleton Campus) arr .... .... 0718 .... 0737 0747 0757 0807 0817 1817 1827 1839 Swansea University (Singleton Campus) dep .... .... 0720 0730 0740 0750 0800 0810 0820 1820 1830 1842 Brynmill Lane .... .... 0724 0734 0744 0754 0804 0814 0824 1824 1834 1846 The Slip .... .... 0727 0737 0747 0757 0807 0817 0827 1827 1837 1849 Civic Centre Level Access .... .... 0730 0740 0750 0800 0810 0820 0830 1830 1840 1852 Civic Centre (via ramp) .... .... 0731 0741 0751 0801 0811 0821 0831 1831 1841 1853 Swansea City Bus Station arr .... .... 0735 0745 0755 0805 0815 0825 0835 and 1835 1845 1857 Swansea City Bus Station dep 0600 0655 0740 0750 0800 0810 0820 0830 0840 at 1840 1850 1902 St Mary's Square 0602 0657 0743 0753 0803 0813 0823 0833 0843 freq- 1843 1853 1905 Rail Station 0605 0700 0747 0757 0807 0817 0827 0837 0847 ent 1847 1857 1909 Stadium 0611 0707 0753 0803 0813 0823 0833 0843 0853 inte- 1853 1903 1915 Plasmarl 0614 0711 0756 0806 0816 0826 0836 0846 0856 rvals 1856 1906 1918 Martin Street 0614 0712 0800 0810 0820 0830 0840 0850 0900 until 1900 1910 1922 Morriston (Woodfield Street) 0615 0713 0802 0812 0822 0832 0842 0852 0902 1902 1912 1924 Morriston Cross 0616 0714 0804 0814 0824 0834 0844 0854 0904 1904 1914 1926 Cwmrhydyceirw.
    [Show full text]
  • Dear Public Health Wales NHS Trust, This Is a Request for the Below
    Dear Public Health Wales NHS Trust, This is a request for the below information under the Freedom of Information Act 2000. Please could you provide me mortality rates for all the hospitals in Wales please from 2000 until 2013 where patients are admitted to stay overnight. I am looking for the number of patients who have passed away in each hospital each year. If I could have the figure as a number and also as a percentage. It would also help to have annual total patient admission numbers for the same period for those hospitals which admit patients overnight too. I have included a list of hospitals below: Bronglais General Hospital Glan Clwyd Hospital Glangwili General Hospital Morriston Hospital Nevill Hall Hospital Prince Charles Hospital Princess of Wales Hospital Royal Glamorgan Hospital Royal Gwent Hospital University Hospital of Wales Withybush General Hospital Wrexham Maelor Hospital Ysbyty Gwynedd Prince Philip Hospital Barry Hospital Brecon War Memorial Hospital Bryn Beryl Hospital Denbigh Community Hospital Dolgellau & Barmouth District Hospital Holywell Community Hospital Llandrindod Wells County War Memorial Hospital Llandudno General Hospital Mold Community Hospital Neath Port Talbot Hospital Singleton Hospital Tywyn Memorial Hospital Victoria Memorial Hospital Ysbyty Alltwen Ysbyty Aneurin Bevan Ysbyty Cwm Cynon Ysbyty Cwm Rhondda Ysbyty Penrhos Stanley Ysbyty Ystrad Fawr Ystradgynlais Community Hospital Pontypridd & District Cottage Hospital (Y Bwthyn) St. Woolos Hospital CHC Local Committee Carmarthenshire Local Committee
    [Show full text]